All Relations between ts and nf1
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| Sunetra Mondal, Neha Agrawal, Subhankar Chowdhur. Turner Syndrome and Neurofibromatosis 1: Rare Co-Existence with Important Clinical Implications. Journal of the ASEAN Federation of Endocrine Societies. vol 38. issue 1. 2023-05-30. PMID:37252421. | co-occurrence of nf1 and ts is extremely rare, ts and nf1 can both affect growth and puberty, cause different cutaneous and skeletal deformities, hypertension, vasculopathy and learning disabilities. | 2023-05-30 | 2023-08-14 | Not clear |
| Markus Uh. [Musculoskeletal manifestations of neurofibromatosis type 1 (von Recklinghausen's disease) and tuberous sclerosis (Bourneville's disease)]. Der Radiologe. vol 61. issue 12. 2021-12-10. PMID:34309712. | neurofibromatosis type 1 (nf1) and tuberous sclerosis (ts) are among the most common genetic diseases. | 2021-12-10 | 2023-08-13 | Not clear |
| Ramya Sivasubramanian, Kevin E Meyer. Hypertension in Children and Adolescents with Turner Syndrome (TS), Neurofibromatosis 1 (NF1), and Williams Syndrome (WS). Current hypertension reports. vol 23. issue 4. 2021-04-26. PMID:33779870. | hypertension in children and adolescents with turner syndrome (ts), neurofibromatosis 1 (nf1), and williams syndrome (ws). | 2021-04-26 | 2023-08-13 | Not clear |
| T C Che. Hereditary neurological tumor syndromes: clues to glioma oncogenesis? Neurosurgical focus. vol 4. issue 4. 2012-10-02. PMID:17168501. | the author reviewed five hereditary neurological tumor syndromes associated with gliomas: li-fraumeni cancer syndrome, neurofibromatosis type 1 (nf1) and type 2 (nf2), tuberous sclerosis (ts), and turcot syndrome. | 2012-10-02 | 2023-08-12 | Not clear |
| H Campbell, N Bradshaw, R Davidson, J Dean, D Goudie, S Holloway, M Porteou. Evidence based medicine in practice: lessons from a Scottish clinical genetics project. Journal of medical genetics. vol 37. issue 9. 2000-11-16. PMID:10978360. | to establish national clinical guidelines and integrated care pathways for five conditions (tuberous sclerosis (ts), huntington's disease (hd), myotonic dystrophy (md), neurofibromatosis type 1 (nf1), and marfan syndrome (ms)) and audit their use in scotland. | 2000-11-16 | 2023-08-12 | Not clear |